Quarterly Sales and EPS Roundup:
Allscripts Healthcare Solutions, Inc. (MDRX) reported sales (ttm) of 1.62 Billion, whereas, 19 number of analysts estimated the mean sale of 430.26 million. The analysts estimated sales for the higher end at 441.1 million and lower end at 423.83 million while the year ago reported sale was 441.57 million.
19 number of analysts have estimated the sales of the company for the quarter, analysts estimated mean sale target of 496.22 million while high and low sale targets are estimated at 543 million and 437.5 million respectively.
Allscripts Healthcare Solutions, Inc. (MDRX) reported earning per shares for the quarter ending Aug 03 AMC, whereas, 22 number of analysts estimated the mean EPS at 0.16. The analysts estimated EPS for the higher end at 0.19 and lower end at 0.14 while the year ago reported earnings per share was 0.18.
The company has mean EPS estimate of 0.18 reported by 22 number of analyst for the quarter ending Current Qtr.(Sep2017). The analysts estimated mean EPS at 0.18 while the high and low EPS estimate stand at 0.2 and 0.16 respectively. In contrast to the year ago quarter EPS was at 0.2. EPS long term mean growth rate estimated by 2 analysts is at 14.05%, whereas, the high and low Long term growth rate estimated at 18 and 10.1.
Valuation Ratios of Allscripts Healthcare Solutions, Inc. (MDRX) versus the Industry and Sector:
Let’s have a look at some of the important valuation ratios of the Allscripts Healthcare Solutions, Inc. (MDRX). These ratios are important while doing valuation of the company or the shares of the company.
Allscripts Healthcare Solutions, Inc. (MDRX) currently the company’s industry has 121.36 P/E and the sector P/E is 33.54. The industry’s and sector’s high P/E for the past year is 72.63 and 44.26 respectively and low P/E ratio for the last 5 years is 21.54 for the industry and 24.62 for the Sector.
Beta is also an important valuation ratio for analyzing the stock of the company, MDRX has Beta of 1.38 while its industry and Sector’s beta remains at 0.91 and 0.95 respectively.
Price to Sale ratio of MDRX stands at 1.35 while Price to Book Ratio stands at 1.99. Its Price to Cash Flow ratio shows the value of 356.27, whereas, the industry and sector ratio of Price to Cash Flow ticked at 18.77 and 24.54 respectively.
5 Year Growth Rate Analysis:
Growth rates are very important while analyzing the long term growth and valuation of a certain company.
5 year sales growth rate is an important factor for valuation analysis, the 5 year sales growth of Allscripts Healthcare Solutions, Inc. (MDRX) stands at 1.42 while the industry’s and the sector’s growth for next 5 years ticked at 3.3 and 10.56 respectively.
Allscripts Healthcare Solutions, Inc. (MDRX) Trading Statistics:
The company declined -0.08% and closed its last trading session at $12.36. The market capitalization of the company is at $2.24 Billion. The stock touched 52-week High of $13.83 on 08/04/17 and 52-week Low of $9.80 on 11/09/16. The stock currently has Weekly Volatility of 3.83% and Monthly Volatility of 3.02%. The Beta for the company stands at 1.39 and its Average True Range (ATR) shows a value of 0.46.